of pitting oedema and swelling, along with calf tenderness. On ultrasonography, the common femoral, superficial, deep femoral and popliteal veins were non-compressible with echogenic thrombi. No flow was observed on a colour Doppler ultrasound, confirming the diagnosis of DVT. A detailed coagulation profile revealed protein C levels of 68% (reference value [RV]: 60−120%), protein S levels of 77% (RV: 60−120%), D-dimer levels of 137 ng/mL (RV: <500 ng/mL), prothrombin time of 15 seconds (RV: 13 seconds), activated partial thromboplastin time of 34 seconds (RV: 28 seconds) and an international normalised ratio (INR) of 1.2. Levels of fibrin degradation products were 3.6 µg/mL (RV: 0−1.34 µg/mL) while antithrombin III levels were 62% (RV: 80−130%). Test results for factor V Leiden and antinuclear antibodies were normal. The patient was administered low-molecular-weight heparin and warfarin. The warfarin was initially prescribed at a dose of 0.1 mg/kg/day with the dose adjusted every third day to achieve an INR of 2−3. The INR was frequently monitored to avoid the possible enzyme induction effects of rifampicin. 1 On the tenth day of admission, the patient developed sudden-onset altered sensorium, aphasia and right-sided haemiparesis. A lumbar puncture was performed to rule out tubercular meningitis; how-ever, examination of the cerebrospinal fluid revealed no abnormalities. A magnetic resonance imaging (MRI) scan of the brain revealed no abnormal findings in the brain parenchyma. There was no evidence of ventricular enlargement, basal exudates or infarcts. There was a hyperintense signal in the left transverse sinus on a T2-weighted fluid attenuated inversion recovery MRI scan. In addition, there was a narrowing of the corresponding sinus on a magnetic resonance venogram [ Figure 2 ], suggestive of intracranial sinus thrombosis. After excluding systemic causes or seizures as possible causes of the altered sensorium and focal deficits, the possibility of cerebral vein thrombosis was considered. The altered sensorium improved over the following two days and the haemiparesis improved over the next 5−7 days, without any residual neurological deficits.
The patient made an uneventful recovery while undergoing the antitubercular and anticoagulation therapy. She became afebrile within two weeks, while the limb oedema and pain improved within four weeks. Her fibrinogen degradation product and antithrombin III levels were normal at four weeks. A repeat ultrasound of the left leg revealed a residual thrombus; however, evidence of partial re-canalisation and flow on a colour Doppler MRI suggested that it was in the process of resolving. She continued to take serology test was non-reactive. Her serum protein levels were 5.1 g/dL. While a chest X-ray was normal, an abdominal X-ray revealed multiple air-fluid levels. Ultrasonography of the abdomen revealed free fluid, matting of the bowel loops, pelvic septations and multiple enlarged mesenteric nodes. A computed tomography scan of the abdomen revealed enlarged mesenteric lymph nodes with stranding of the mesentery [ Figure 1 ], indicating a tubercular aetiology. There was no evidence of compression of the inferior vena cava by the lymph nodes. A gastric lavage was positive for acid-fast bacilli. Consequently, a diagnosis of probable abdominal TB was made and the patient was prescribed four-drug antitubercular therapy three days after admission, comprised of rifampicin, isoniazid, pyrazinamide and ethambutol.
Later that day, the patient developed pain and swelling in the left leg and thigh. There was evidence low-molecular-weight heparin for 10 days, warfarin for three months and antitubercular drugs for six months. Regular follow-up appointments over the next six months indicated that she was in good health and had gained 11 kg. Unfortunately, the patient was subsequently lost to follow-up.
Discussion
Severe TB is known to induce an acute phase response which leads to the activation of mononuclear cells; the interaction of mycobacterial products with activated mononuclear cells subsequently induces increased synthesis of tumour necrosis factor-α and interleukin-6. 6, 7 These proinflammatory cytokines activate the vascular intima, rendering the endothelial surface thrombogenic. The cytokines also induce a hepatic acute phase response leading to deranged levels of coagulation proteins and a subsequent hypercoagulable state. 6, 7 There are very few reports of thrombotic complications among children with TB, possibly due to under-reporting. 3, 4 This type of rare but serious complication can further increase the morbidity and mortality associated with TB in young children; 8 as such, clinicians should keep a high index of suspicion of DVT. To the best of the authors' knowledge, this is the first reported case of childhood abdominal TB with DVT and intracranial sinus thrombosis.
Robson et al. reported 35 cases of pulmonary TB and DVT in adults; of these, venous thrombosis occurred seven days after diagnosis for 33 patients, while two had DVT upon presentation. 6 The patient in the present case developed symptoms of DVT on the third day of admission, before the commencement of antitubercular therapy. Elevated plasma fibrinogen, impaired fibrinolysis, decreased levels of antithrombin III and reactive thrombocytosis can lead to the development of DVT among patients with pulmonary TB. 6 A hypercoagulable state in patients with TB has been reported to improve within four weeks with the use antitubercular drugs. 7 In the current case, the patient had elevated levels of fibrin degradation products and decreased levels of antithrombin III which resolved within a month of antitubercular therapy.
TB can predispose to DVT due to a hypercoagulable state. 6 Retroperitoneal tubercular lymphadenitis leading to compression of the inferior vena cava has also been reported to cause DVT in the absence of any haemostatic abnormalities. 9 Immobility can further exacerbate the effects of a hypercoagulable state. Although the patient in the present case was diagnosed with probable abdominal TB with mesenteric lymphadenitis, there was no evidence of inferior vena cava compression. Thus, the DVT and intracranial sinus thrombosis were possibly due to the patient's hypercoagulable state.
Isoniazid and rifampicin can exacerbate the thrombogenic potential of TB by killing mycobacteria and enhancing the release of interleukin-6 from the peripheral blood mononuclear cells. 1 Rifampicin is a potent inducer of cytochrome P450 proteins and thus enhances metabolism of oral anticoagulants; 1 as a result, adjustments to the dosage of warfarin may be necessary to maintain its therapeutic efficacy. Doses and durations of anticoagulant treatment for patients with TB have not yet been standardised. The recommended duration of anticoagulants for children with secondary and idiopathic venous thrombosis is three and six months, respectively. 10 It has been suggested that the hypercoagulable state and haemostatic changes stabilise within four weeks of antitubercular therapy. 7 In the current patient, the DVT resolved within a month of antitubercular treatment, which provides further evidence of a correlation between TB and venous thrombosis.
Conclusion
While DVT is a rare complication associated with pulmonary and extrapulmonary TB in adult patients, reports of this complication occurring with childhood TB are scarce. There is a need to keep a high index of suspicion of this rare but serious complication as it can further increase the morbidity and mortality associated with TB in young children. In addition, the current case highlights for the first time a possible association between childhood TB and intracranial sinus thrombosis.
